---
figid: PMC5657420__sigtrans20161-f1
figlink: /pmc/articles/PMC5657420/figure/fig1/
number: F1
caption: The classical pRb pathway demonstrates the utility of CDK inhibitors, such
  as palbociclib, in RB+/+ osteosarcoma. In this case, treatment of RB+/+ tumors with
  palbociclib would result in proliferation arrest and senescence as cells exit the
  cell cycle. In addition to its role as cell cycle regulator (pictured), pRb also
  serves as a transcriptional coactivator of Runx2 and thus promotes osteogenic differentiation
  (not pictured).
pmcid: PMC5657420
papertitle: 'Osteosarcoma: prognosis plateau warrants retinoblastoma pathway targeted
  therapy.'
reftext: Sarah E Ballatori, et al. Signal Transduct Target Ther. 2016;1:16001.
pmc_ranked_result_index: '38779'
pathway_score: 0.9021159
filename: sigtrans20161-f1.jpg
figtitle: Classical pRb pathway demonstrates the utility of CDK inhibitors, such as
  palbociclib, in RB+/+ osteosarcoma
year: '2016'
organisms:
- Mus musculus
- Betapolyomavirus macacae
- Homo sapiens
ndex: 98dd16e9-df08-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5657420__sigtrans20161-f1.html
  '@type': Dataset
  description: The classical pRb pathway demonstrates the utility of CDK inhibitors,
    such as palbociclib, in RB+/+ osteosarcoma. In this case, treatment of RB+/+ tumors
    with palbociclib would result in proliferation arrest and senescence as cells
    exit the cell cycle. In addition to its role as cell cycle regulator (pictured),
    pRb also serves as a transcriptional coactivator of Runx2 and thus promotes osteogenic
    differentiation (not pictured).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCND3
  - E2F7
  - CCNE2
  - E2F3
  - CDK2
  - CCNE1
  - CCND2
  - E2F6
  - E2F8
  - CCND1
  - MLIP
  - CDKN2A
  - CIB1
  - E2F1
  - CDK4
  - CDK6
  - E2F4
  - E2F5
  - E2F2
genes:
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CIP/KIP
  symbol: CIP
  source: hgnc_alias_symbol
  hgnc_symbol: MLIP
  entrez: '90523'
- word: INK4
  symbol: INK4
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: CIP/KIP
  symbol: KIP
  source: hgnc_alias_symbol
  hgnc_symbol: CIB1
  entrez: '10519'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: CDK4/CDK6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK4/CDK6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
chemicals: []
diseases: []
figid_alias: PMC5657420__F1
redirect_from: /figures/PMC5657420__F1
figtype: Figure
---
